Weight-loss stocks soar up to 15% after obesity-drug study shows an added benefit that may be a 'huge win' for future sales

Wall Street’s enthusiasm for all things weight-loss related got a fresh boost Tuesday after results for a Novo Nordisk A/S obesity drug showed a heart benefit. Weight-loss tied stocks jumped following the update with rival Eli Lilly & Co. surging 15% to a record high. A positive outlook in Lilly’s…

#anovonordiskas #elilillyco #lilly #novoswegovy #wwinternationalinc #weightwatchers #mohitbansal #wellsfargo #truist #joonlee